Local councils on the frontline: tackling nitazenes and drug-related deaths in England

In response to the nitazene threat, many councils have ramped up efforts to distribute naloxone kits to at-risk populations, including people who use drugs, their families, and frontline workers.


Last year, England faced a grim milestone: drug-related deaths surged to their highest levels since records began, with a sharp and alarming rise in fatalities linked to nitazenes—a group of synthetic opioids up to 500 times more potent than heroin.

As the crisis deepens, local councils are emerging as critical players in the fight to save lives, particularly through the distribution of naloxone, a life-saving opioid overdose reversal drug.

Nitazenes, originally developed in the 1950s, have re-emerged on the illicit drug market. Often mixed with heroin, cocaine, or counterfeit pills, these synthetic opioids are difficult to detect and extremely lethal even in minute doses.

Between June 2023 and May 2024, at least 284 deaths in the UK were linked to nitazenes, prompting urgent action from public health bodies and law enforcement. While national agencies like the Office for Health Improvement and Disparities (OHID) and the National Crime Agency (NCA) track and analyse overdose data, it is local councils that are often first to respond on the ground. Councils are responsible for public health services, including drug treatment programs and harm reduction initiatives.

In response to the nitazene threat, many councils have ramped up efforts to distribute naloxone kits to at-risk populations, including people who use drugs, their families, and frontline workers.

Naloxone can reverse the effects of opioid overdose within minutes, buying critical time for emergency services to arrive. However, its effectiveness against nitazenes is still being studied, as these synthetic opioids may require higher or repeated doses to counteract their potency. 

Despite these challenges, expanding access to naloxone remains a cornerstone of harm reduction. Local authorities are working with charities, pharmacies, and outreach teams to ensure the drug is widely available and that communities are educated on its use.

Local councils face significant hurdles: funding constraints, stigma around drug use, and the ever-evolving nature of the illicit drug market. Yet, their role is more crucial than ever. By integrating naloxone distribution into broader public health strategies and advocating for national support, councils can help stem the tide of preventable deaths.

In Greater Manchester for example, local authorities have pioneered community naloxone access points, including pharmacies and homeless shelters. These efforts are part of a broader harm reduction strategy that includes peer-led outreach and real-time drug alert systems. The region’s Combating Drugs Partnership has also emphasised data sharing and rapid response protocols.

Bristol has implemented a robust take-home naloxone program that includes training for people who use drugs, their families, and community workers. The council works closely with local charities and peer-led organisations to ensure naloxone is available in hostels, drop-in centres, and even through mobile outreach teams.

Recognising the challenges of rural drug use, Durham County Council has equipped not only drug services but also police officers and fire crews with naloxone. This ensures that first responders in remote areas can administer the drug quickly in overdose situations.

Liverpool has partnered with local pharmacies to make naloxone more accessible. Pharmacies across the city now offer free naloxone kits without a prescription, and pharmacists are trained to provide brief overdose prevention education. This model has helped normalise naloxone as a public health tool and reduce stigma. 

The Government’s Synthetic Opioids Taskforce, launched in 2024, aims to support these efforts by enhancing surveillance, sharing toxicology data, and coordinating responses across agencies. But lasting change will require sustained investment, political will, and community engagement.

The rise of nitazenes has added a deadly new dimension to England’s drug challenges, while the national picture may be daunting, local action is both possible and powerful. Councils are not waiting for permission—they are acting, adapting, and saving lives.

As the synthetic opioid crisis evolves, continued investment in harm reduction, community education, and cross-sector collaboration will be essential. Naloxone is not a silver bullet, but in the hands of informed communities, it is a vital tool in the fight to prevent needless deaths.